SHCI Board of Directors
The Board of Directors shapes the vision and implements the objectives and policy of the Society for Healthcare Innovation.
Our team is composed of leaders in their respective fields, committed to the mission of SHCI to advance innovation in healthcare.
Dmitriy Petrov, MD is an Assistant Professor in the Department of Neurosurgery at the Univeristy of Pennsylvania. His clinical interests are in cranial and skull base surgery.
His research program focuses on translation models of neurotrauma and the development of novel diagnostic and therapeutic modalities for patients with significant head trauma. Dmitriy is also the founder of the TBI Recovery Project, a nonprofit organization supporting the traumatic brain injury community.
He is committed to pushing healthcare innovation forward, in both surgical technology and in healthcare operations to optimize patient outcomes.
Executive Board Member
Corey Feldman, MBA is the VP of Business Development at Emmacare, an interactive platform that empowers care managers to more efficiently and effectively monitor patients who suffer from chronic disease.
Corey served in a special operations unit of the IDF in Israel, and currently holds the rank of Staff Sergeant in the IDF reserves.
Corey holds a BA in Political Science from the University of Pennsylvania, an MBA from the Quantic School of Business and Technology, and is a candidate for the Master of Health Care Innovation at the School of Medicine of the University of Pennsylvania.
Krzysztof “Kris” Laudanski, MD, PhD, MHCI is an Assistant Professor in the Department of Anesthesiology and Critical Care at the University of Pennsylvania. He is board-certified in both anesthesiology and critical care and he is a Fellow of Critical Care Medicine.
Kris's clinical experience focuses on managing all aspects of intensive care, including ECMO and VAD.
As an NIH-funded researcher at PennMedicine, his interests focus on the impact of critical care on the immune system, the epigenetic regulation of the immune system on homeostasis, sepsis, and postoperative recovery and cognitive decline.
Kris holds degrees from the University of Pennsylvania and University of Warsaw.
Gabriela Sabaté, MBA, MHCI is an entrepreneur, executive, and investor with a 25-year US and international career in creating and leading new ventures in healthcare, tech and biotechnology.
Currently CEO of Health Semantics, she held executive positions at SoftBank, IBM, and Tiaxa. With a multidisciplinary background in innovation, engineering, healthcare, and translational research, her current focus is on developing technologies and scientific collaborations that can transform care delivery, increase prevention and maximize data assets through AI, telemedicine, and cloud computing.
Gabriela holds degrees from UBA, UF, and the School of Medicine of the University of Pennsylvania.
Atul Kalanuria, MD, FACP, MHCI is an internist and a neurologist with specialization in neurocritical care at the University of Pennsylvania. During his 20-year career in medicine, he has worked in diverse clinical settings ranging from rural centers to tertiary care hospitals. As an educator, he has been involved in creating educational materials and curricula for medical trainees. He firmly believes in improving healthcare through optimizing operations and has advised industry players on strategic planning and execution. He believes that US and global healthcare can be transformed through innovation and success can be achieved with cross-industry collaboration.